A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies

Author: Paik Paul   Rudin Charles   Brown Andrew   Rizvi Naiyer   Takebe Naoko   Travis William   James Leonard   Ginsberg Michelle   Juergens Rosalyn   Markus Susan   Tyson Leslie   Subzwari Sara   Kris Mark   Krug Lee  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.66, Iss.6, 2010-11, pp. : 1079-1085

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content